Not known Factual Statements About Ago tumor
Founded immune markers continue to protect their relevance for clinical decision-making in breast cancer cure with even extended meanings. Estrogen receptor (ER) amount mustn't only be categorized in constructive or damaging. Reduced ER levels ≤10% of labeled cells needs to be dealt with in another way (LoE 1a/A/Back++). Tumors with small ER leve